218 related articles for article (PubMed ID: 8529521)
1. The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.
Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S67-80. PubMed ID: 8529521
[TBL] [Abstract][Full Text] [Related]
2. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride.
Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
Biochim Biophys Acta; 1994 May; 1191(2):278-90. PubMed ID: 8172913
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells.
Kramer W; Müller G; Geisen K
Horm Metab Res; 1996 Sep; 28(9):464-8. PubMed ID: 8911984
[TBL] [Abstract][Full Text] [Related]
4. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics.
Müller G; Hartz D; Pünter J; Okonomopulos R; Kramer W
Biochim Biophys Acta; 1994 May; 1191(2):267-77. PubMed ID: 8172912
[TBL] [Abstract][Full Text] [Related]
5. Direct photoaffinity labeling of the putative sulfonylurea receptor in rat beta-cell tumor membranes by [3H]glibenclamide.
Kramer W; Oekonomopulos R; Pünter J; Summ HD
FEBS Lett; 1988 Mar; 229(2):355-9. PubMed ID: 2831099
[TBL] [Abstract][Full Text] [Related]
6. Photoaffinity labeling of the cerebral sulfonylurea receptor using a novel radioiodinated azidoglibenclamide analogue.
Schwanstecher M; Löser S; Chudziak F; Bachmann C; Panten U
J Neurochem; 1994 Aug; 63(2):698-708. PubMed ID: 8035194
[TBL] [Abstract][Full Text] [Related]
7. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
[TBL] [Abstract][Full Text] [Related]
8. The mitochondrial sulfonylurea receptor: identification and characterization.
Szewczyk A; Wójcik G; Lobanov NA; Nałecz MJ
Biochem Biophys Res Commun; 1997 Jan; 230(3):611-5. PubMed ID: 9015372
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a 65 kDa sulfonylurea receptor in rat pancreatic zymogen granule membranes.
Braun M; Anderie I; Thévenod F
FEBS Lett; 1997 Jul; 411(2-3):255-9. PubMed ID: 9271216
[TBL] [Abstract][Full Text] [Related]
10. Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.
Stephan D; Winkler M; Kühner P; Russ U; Quast U
Diabetologia; 2006 Sep; 49(9):2039-48. PubMed ID: 16865362
[TBL] [Abstract][Full Text] [Related]
11. Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity.
Kawaki J; Nagashima K; Tanaka J; Miki T; Miyazaki M; Gonoi T; Mitsuhashi N; Nakajima N; Iwanaga T; Yano H; Seino S
Diabetes; 1999 Oct; 48(10):2001-6. PubMed ID: 10512365
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR
J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic and extrapancreatic sulfonylurea receptors.
Panten U; Schwanstecher M; Schwanstecher C
Horm Metab Res; 1992 Dec; 24(12):549-54. PubMed ID: 1478610
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes.
Hambrock A; Löffler-Walz C; Russ U; Lange U; Quast U
Mol Pharmacol; 2001 Jul; 60(1):190-9. PubMed ID: 11408614
[TBL] [Abstract][Full Text] [Related]
15. The beta-cell response to oral hypoglycemic agents.
Cook DL
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S81-9. PubMed ID: 8529522
[TBL] [Abstract][Full Text] [Related]
16. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
Gribble FM; Tucker SJ; Seino S; Ashcroft FM
Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
[TBL] [Abstract][Full Text] [Related]
17. Sulfonylurea receptors and mechanism of sulfonylurea action.
Panten U; Schwanstecher M; Schwanstecher C
Exp Clin Endocrinol Diabetes; 1996; 104(1):1-9. PubMed ID: 8750563
[TBL] [Abstract][Full Text] [Related]
18. Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic beta-cell line and rat cerebral cortex.
Schwanstecher M; Brandt C; Behrends S; Schaupp U; Panten U
Br J Pharmacol; 1992 Jun; 106(2):295-301. PubMed ID: 1393263
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacology of glimepiride].
Satoh Y
Nihon Rinsho; 1997 Nov; 55 Suppl():147-51. PubMed ID: 9434459
[No Abstract] [Full Text] [Related]
20. Inhibition of K+ channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets.
Schwanstecher M; Mnner K; Panten U
Pharmacology; 1994 Aug; 49(2):105-11. PubMed ID: 7972319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
